The overall survival analysis using the Kaplan–Meyer method revealed that the prognosis of CRC patients with no or weak MSP58 expression was significantly better than those with high or moderate MSP58 expression, and moderate expression was better than high expression (see Fig. 1; P < 0.001). The gene discussed is MCRS1; the disease is colorectal carcinoma.